Investment Analysts’ Updated EPS Estimates for January 20th (AAPL, ABCL, ALLT, AMGN, ASML, AVB, BATS, BP, BYG, CIEN)

Investment Analysts’ updated eps estimates for Tuesday, January 20th:

Apple (NASDAQ:AAPL) had its outperform rating reissued by analysts at Evercore ISI. Evercore ISI currently has a $330.00 target price on the stock.

AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Allot (NASDAQ:ALLT) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $12.50 target price on the stock.

Amgen (NASDAQ:AMGN) was downgraded by analysts at Sanford C. Bernstein from an outperform rating to a market perform rating. Sanford C. Bernstein currently has $335.00 target price on the stock.

ASML (NASDAQ:ASML) had its buy rating reaffirmed by analysts at UBS Group AG.

AvalonBay Communities (NYSE:AVB) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating. They currently have $172.00 target price on the stock.

British American Tobacco (LON:BATS) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 5,200 price target on the stock.

BP (LON:BP) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 440 target price on the stock.

Big Yellow Group (LON:BYG) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 1,383 target price on the stock.

Ciena (NYSE:CIEN) had its neutral rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a $260.00 target price on the stock.

Clover Health Investments (NASDAQ:CLOV) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a $3.70 target price on the stock.

ConocoPhillips (NYSE:COP) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $98.00 target price on the stock.

Craneware (LON:CRW) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 2,900 price target on the stock.

Craneware (LON:CRW) had its buy rating reiterated by analysts at Shore Capital. Shore Capital currently has a GBX 2,850 price target on the stock.

Cenovus Energy (NYSE:CVE) (TSE:CVE) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

DFS Furniture (LON:DFS) had its no recommendation rating reaffirmed by analysts at Shore Capital.

Domino’s Pizza (NASDAQ:DPZ) had its equal weight rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $455.00 target price on the stock, down from their previous target price of $535.00.

Entain (LON:ENT) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 1,200 target price on the stock.

Evoke (LON:EVOK) had its hold rating reiterated by analysts at Berenberg Bank. They currently have a GBX 33 target price on the stock.

Eagle Eye Solutions Group (LON:EYE) had its house stock rating reissued by analysts at Shore Capital.

FedEx (NYSE:FDX) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

4imprint Group (LON:FOUR) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 5,140 price target on the stock.

Gloo (NASDAQ:GLOO) had its buy rating reiterated by analysts at Roth Capital. The firm currently has a $17.00 target price on the stock.

ImmunityBio (NASDAQ:IBRX) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $24.00 price target on the stock.

Intel (NASDAQ:INTC) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $30.00 target price on the stock.

IperionX (NASDAQ:IPX) had its buy rating reiterated by analysts at Roth Capital. They currently have a $74.00 target price on the stock.

Legend Biotech (NASDAQ:LEGN) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $66.00 target price on the stock.

Logitech International (NASDAQ:LOGI) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $135.00 price target on the stock.

Logitech International (NASDAQ:LOGI) had its underweight rating reiterated by analysts at Morgan Stanley. The firm currently has a $89.00 price target on the stock, down from their previous price target of $107.00.

MongoDB (NASDAQ:MDB) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $500.00 target price on the stock.

Midwich Group (LON:MIDW) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 350 price target on the stock.

Micron Technology (NASDAQ:MU) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $500.00 target price on the stock.

Novavax (NASDAQ:NVAX) had its buy rating reissued by analysts at BTIG Research. They currently have a $19.00 target price on the stock.

OceanFirst Financial (NASDAQ:OCFC) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Ocugen (NASDAQ:OCGN) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $7.00 target price on the stock.

Oportun Financial (NASDAQ:OPRT) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

QinetiQ Group (LON:QQ) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 550 target price on the stock.

Rapt Therapeutics (NASDAQ:RAPT) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating. The firm currently has $58.00 target price on the stock.

Rapt Therapeutics (NASDAQ:RAPT) had its hold rating reissued by analysts at TD Cowen.

Regions Financial (NYSE:RF) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $31.00 price target on the stock.

RLX Technology (NYSE:RLX) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Seplat Energy (LON:SEPL) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 550 target price on the stock.

System1 Group (LON:SYS1) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 550 price target on the stock.

Turn Therapeutics (NASDAQ:TTRX) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $8.00 target price on the stock.

W.R. Berkley (NYSE:WRB) had its sell rating reiterated by analysts at TD Cowen. They currently have a $55.00 price target on the stock, down from their previous price target of $77.00.